MONOCLONAL ANTI-IL-2 RECEPTOR ANTIBODY IN PRIMATE RENAL-TRANSPLANTATION

被引：0
|
作者：
SHAPIRO, ME
KIRKMAN, RL
REED, MH
PUSKAS, JD
MAZOUJIAN, G
LETVIN, NL
CARPENTER, CB
MILFORD, EL
WALDMANN, TA
STROM, TB
SCHLOSSMAN, SF
机构：
[1] NEW ENGLAND REG PRIMATE RES CTR,DANA FARBER CANC INST,SOUTHBOROUGH,MA 01772
[2] BETH ISRAEL HOSP,DEPT SURG,BOSTON,MA 02215
[3] BETH ISRAEL HOSP,DEPT MED,BOSTON,MA 02215
[4] BETH ISRAEL HOSP,DEPT PATHOL,BOSTON,MA 02215
[5] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[6] NCI,METAB BRANCH,BETHESDA,MD 20205
来源：
TRANSPLANTATION PROCEEDINGS | 1987年 / 19卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：594 / 598
页数：5
相关论文
共 50 条
  • [21] DELAYED ALLOGRAFT-REJECTION IN PRIMATES TREATED WITH ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY CAMPATH-6
    TIGHE, H
    FRIEND, PJ
    COLLIER, SJ
    DECURTINS, M
    LIM, S
    COBBOLD, SP
    THIRU, S
    CALNE, RY
    WALDMANN, H
    TRANSPLANTATION, 1988, 45 (01) : 226 - 228
  • [22] ANTI-CD3 - ANTI-IL-2 RECEPTOR BISPECIFIC MONOCLONAL-ANTIBODY - TARGETING OF ACTIVATED T-CELLS INVITRO
    MACLEAN, JA
    SU, Z
    GUO, Y
    SY, MS
    COLVIN, RB
    WONG, JT
    JOURNAL OF IMMUNOLOGY, 1993, 150 (04): : 1619 - 1628
  • [23] SYNERGISTIC INHIBITION OF CYTOKINE PRODUCTION, AND PROLONGATION OF RAT RENAL-ALLOGRAFT SURVIVAL BY ANTI-IL-2 RECEPTOR (IL-2R) MONOCLONAL-ANTIBODY (MAB) AND CYCLOSPORINE (CSA)
    HANCOCK, WW
    UEDA, H
    KUPIECWEGLINSKI, J
    TILNEY, N
    KIDNEY INTERNATIONAL, 1990, 38 (03) : 560 - 560
  • [24] INDUCTION THERAPY IN RENAL TRANSPLANTATION WITH MAASTRICHT TYPE III NON-HEART BEATING DONORS: COMPARISON BETWEEN ANTI-IL-2 RECEPTOR ANTIBODY AND POLYCLONAL ANTI-LYMPHOCYTE ANTIBODY
    Bailly, E.
    Tassery, M.
    Venhard, J. C.
    Videcoq, M.
    Kerforne, T.
    Boutin, J. M.
    Delpech, P. O.
    Branchereau, J.
    Dantal, J.
    Thierry, A.
    Buchler, M.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
  • [25] TREATMENT WITH LO-TACT-1, A MONOCLONAL-ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR, IN RENAL-TRANSPLANTATION
    HIESSE, C
    LANTZ, O
    KRIAA, F
    NOURY, J
    FRIES, D
    CHARPENTIER, B
    BAZIN, H
    PRESSE MEDICALE, 1991, 20 (40): : 2036 - 2038
  • [26] A RANDOMIZED PROSPECTIVE TRIAL OF ANTI-TAC MONOCLONAL-ANTIBODY IN HUMAN RENAL-TRANSPLANTATION
    KIRKMAN, RL
    SHAPIRO, ME
    CARPENTER, CB
    MCKAY, DB
    MILFORD, EL
    RAMOS, EL
    TILNEY, NL
    WALDMANN, TA
    ZIMMERMAN, CE
    STROM, TB
    TRANSPLANTATION, 1991, 51 (01) : 107 - 113
  • [27] A CHIMERIC MOUSE HUMAN ANTI-IL-2 RECEPTOR ANTIBODY WITH ENHANCED BIOLOGICAL-ACTIVITIES
    ROSE, B
    GILLESPIE, A
    WUNDERLICH, D
    BARBOSA, JA
    CAHILL, K
    DZUIBA, J
    SHEDD, D
    ZERLER, B
    MOLECULAR IMMUNOLOGY, 1992, 29 (01) : 131 - 144
  • [28] IMMUNOSUPPRESSION WITH MONOCLONAL ANTI-T3 ANTIBODY (WT32) IN RENAL-TRANSPLANTATION
    TAX, WJM
    VANDEHEIJDEN, HMW
    WILLEMS, HW
    HOITSMA, AJ
    BERDEN, JHM
    CAPEL, PJA
    KOENE, RAP
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1905 - 1907
  • [29] A RANDOMIZED PROSPECTIVE TRIAL OF ANTI-TAC MONOCLONAL-ANTIBODY IN HUMAN RENAL-TRANSPLANTATION
    KIRKMAN, RL
    SHAPIRO, ME
    CARPENTER, CB
    MCKAY, DB
    MILFORD, EL
    RAMOS, EL
    TILNEY, NL
    WALDMANN, TA
    ZIMMERMAN, CE
    STROM, TB
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1066 - 1067
  • [30] SELECTIVE ELIMINATION INVITRO OF ALLORESPONSIVE T-CELLS TO HUMAN TRANSPLANTATION ANTIGENS BY TOXIN OR RADIONUCLIDE CONJUGATED ANTI-IL-2 RECEPTOR (TAC) MONOCLONAL-ANTIBODY
    KOZAK, RW
    FITZGERALD, DP
    ATCHER, RW
    GOLDMAN, CK
    NELSON, DL
    GANSOW, OA
    PASTAN, I
    WALDMANN, TA
    JOURNAL OF IMMUNOLOGY, 1990, 144 (09): : 3417 - 3423
12345